Ethical Issues Raised by Proposals to Treat Addiction Using Deep Brain Stimulation

Neuroethics ◽  
2010 ◽  
Vol 4 (2) ◽  
pp. 129-142 ◽  
Author(s):  
Adrian Carter ◽  
Emily Bell ◽  
Eric Racine ◽  
Wayne Hall
2021 ◽  
pp. 405-420
Author(s):  
Georg Northoff

Neuroethics, located at the interface of conceptual and empirical dimensions, carries major implications for psychiatry, such as the neuroscientific basis of ethical concepts as moral agency. Drawing on data in neuroscience, this chapter highlights issues central to psychiatric ethics. First, it addresses a reductionistic model of the brain, often conceived as purely neuronal, and then it discusses empirical data suggesting that the brain’s activity is strongly aligned to its respective social (e.g., relation to others) and ecological (e.g., relation to the environment and nature) contexts; this implies a relational rather than reductionist model. Second, it suggests that self (e.g., the experience or sense of a self) and personhood (e.g., the person as existent independent of experience) must also be understood in such a social and ecological and, therefore, relational and spatio-temporal sense. Ethical concepts like agency, therefore, cannot be limited solely to the person and brain, but must rather be understood in a relational and neuro-ecological/social way. Third, it discusses deep brain stimulation as a treatment that promotes enhancement. In sum, this chapter presents findings in neuroscience that carry major implications for our view of brain, mental features, psychiatric disorders, and ethical issues like agency, responsibility, and enhancement.


2021 ◽  
Vol 15 ◽  
Author(s):  
Vinata Vedam-Mai ◽  
Karl Deisseroth ◽  
James Giordano ◽  
Gabriel Lazaro-Munoz ◽  
Winston Chiong ◽  
...  

We estimate that 208,000 deep brain stimulation (DBS) devices have been implanted to address neurological and neuropsychiatric disorders worldwide. DBS Think Tank presenters pooled data and determined that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. The DBS Think Tank was founded in 2012 providing a space where clinicians, engineers, researchers from industry and academia discuss current and emerging DBS technologies and logistical and ethical issues facing the field. The emphasis is on cutting edge research and collaboration aimed to advance the DBS field. The Eighth Annual DBS Think Tank was held virtually on September 1 and 2, 2020 (Zoom Video Communications) due to restrictions related to the COVID-19 pandemic. The meeting focused on advances in: (1) optogenetics as a tool for comprehending neurobiology of diseases and on optogenetically-inspired DBS, (2) cutting edge of emerging DBS technologies, (3) ethical issues affecting DBS research and access to care, (4) neuromodulatory approaches for depression, (5) advancing novel hardware, software and imaging methodologies, (6) use of neurophysiological signals in adaptive neurostimulation, and (7) use of more advanced technologies to improve DBS clinical outcomes. There were 178 attendees who participated in a DBS Think Tank survey, which revealed the expansion of DBS into several indications such as obesity, post-traumatic stress disorder, addiction and Alzheimer’s disease. This proceedings summarizes the advances discussed at the Eighth Annual DBS Think Tank.


2006 ◽  
Vol 5 ◽  
pp. 33-38
Author(s):  
Elizabeth Hildt

In the following text, medical, anthropological and ethical issues of deep brain stimulation, a medical technology in which electrodes implanted in the human brain electrically influence specified brain regions, will be discussed. After a brief account of the deep brain stimulation procedure and its chances and risks, anthropological and ethical aspects of the approach will be discussed. These relate to the reversibility of the procedure and to the patient?s capacity to control the effects it exerts in the brain, to modifications and fluctuations in a person?s character traits and individuality brought about by neurostim ulation, an d to the range of legitim ate, adequate uses of the deep brain stimulation approach. The paper concludes that deep brain stimulation should be confined to therapeutic contexts and to severe, otherwise treatment-refractory disorders in which the aim is to norm alize brain fun ctioning. A part from this, it sh ould not be used to m odify a person?s individ ual character traits and behaviour or to enhance human traits.


2016 ◽  
Vol 9 (5) ◽  
pp. 788-789
Author(s):  
Joan Trujols ◽  
María José Manresa ◽  
Francesca Batlle ◽  
Santiago Duran-Sindreu ◽  
José Pérez de los Cobos

2011 ◽  
Vol 2 (1) ◽  
pp. 29-36 ◽  
Author(s):  
Laura B. Dunn ◽  
Paul E. Holtzheimer ◽  
Jinger G. Hoop ◽  
Helen S. Mayberg ◽  
Laura Weiss Roberts ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document